OSUR OraSure Technologies, Inc.: Rasio total nilai perusahaan marang pendapatan

Logo perusahaan publik OraSure Technologies, Inc. (OSUR)

OraSure Technologies (OSUR) is transforming its model toward molecular diagnostics and clinical rapid tests. Effective pharmacy distribution and supply chain protection support high margins. The company's valuation based on the EV/Sales multiple reflects market expectations, where 1014.37 determines this parameter level. Production precision is ensured by robotic assembly lines that minimize manual labor.

OSUR Rasio nilai perusahaan marang pendapatan OraSure Corp (23.11.2025 - 20.11.2026)

Rincian metrik keuangan lan pasar OraSure Technologies Inc (OSUR)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental:OraSure Technologies (OSUR)
Barang utama OraSure Technologies, Inc.

This metric compares the combined value of assets and debt against annual sales volume, excluding the impact of leverage. It measures the market premium per unit of revenue, signaling a business overvaluation during sharp spikes in demand. Patent protection and FDA approvals for OraSure Technologies (OSUR) create a sustainable barrier that justifies the high cost of operational resilience. By analyzing the business value-to-revenue dynamics, an investor can identify trend reversal points, allowing for the timely determination of the optimal moment to open positions.

Analisis pesaing OraSure Technologies

A (Agilent) - Rasio nilai perusahaan marang pendapatan|DGX (Quest Diagnostics) - Nilai perusahaan marang pendapatan|Illumina Inc (ILMN) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan EXAS|Revvity, Inc. (RVTY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales BIO|NNNN (Anbio Biotechnology) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales SHC (Sotera Health)|Quidel Corporation (QDEL) - Multiplikator nilai perusahaan marang pendapatan|OPK - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - Multiplikator EV/Sales|Cytek Biosciences (CTKB) - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan XGN (Exagen Diagnostics)|Rasio total nilai perusahaan marang pendapatan MDxHealth Inc.|Rasio nilai perusahaan marang pendapatan Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Multiplikator nilai perusahaan marang pendapatan|Insight Molecular Diagnostics Inc - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan trinitybiotech.com|PRPH (ProPhase) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AIMD|Nilai perusahaan marang pendapatan CODX|Multiplikator nilai perusahaan marang pendapatan heartsciences.com HSCS|Rasio nilai perusahaan marang pendapatan Biomerica Inc. (BMRA)|Rasio total nilai perusahaan marang pendapatan Cardio Diagnostics Holdings|Multiplikator EV/Sales ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Multiplikator nilai perusahaan marang pendapatan|bluejaydx.com - Multiplikator EV/Sales|Aspira Women's Health - Koefisien nilai perusahaan marang pendapatan|AXDX (Accelerate Diagnostics) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan CENTOGENE, N.V.|Rasio nilai perusahaan marang pendapatan enzo.com|Multiplikator EV/Sales Fresh2 Group Limited|Multiplikator EV/Sales GENE|23andMe Holding Co. - Rasio nilai perusahaan marang pendapatan|Psychemedics Inc - Nilai perusahaan marang pendapatan